Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04393935 · ClinicalTrials.gov registry record · NA
Pharmacy-based Pre-exposure Prophylaxis
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 49
- Enrollment target
NCT04393935 is a NA study that has completed, run by Emory University. The registered enrollment target is 49 participants.
The verdict
NCT04393935, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 49 participants
- Enrollment target
Study Summary
The proposed research will develop a culturally appropriate pharmacy pre-exposure prophylaxis (PrEP) delivery model for black men who have sex with men (BMSM) who live in high poverty, racial minority neighborhoods. Increasing access to PrEP through pharmacies has the potential to increase PrEP uptake among BMSM thereby reducing HIV incidence and racial inequities in HIV.
Interventions
- BEHAVIORAL Pharmacy Delivered PrEP Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2022-05-19 |
| Est. Completion | 2024-05-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04393935
The ClinicalTrials.gov registry entry for NCT04393935 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pharmacy Delivered PrEP Intervention is the first listed.
NCT04393935 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04393935 about?
NCT04393935 is a clinical study titled "Pharmacy-based Pre-exposure Prophylaxis". The proposed research will develop a culturally appropriate pharmacy pre-exposure prophylaxis (PrEP) delivery model for black men who have sex with men (BMSM) who live in high poverty, racial minority neighborhoods. Increasing access to PrEP through pharmacies has the potential to increase PrEP upta...
What is the current status of trial NCT04393935?
This trial is currently completed. It is a NA study. The enrollment target is 49 participants. The study started on 2022-05-19. Estimated completion is 2024-05-11.
What interventions are being tested in trial NCT04393935?
The interventions under investigation include: Pharmacy Delivered PrEP Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04393935?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.